BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 14, 2004
View Archived Issues
Eszopiclone for insomnia subject of several studies presented at sleep conference
Read More
5-HT2a inverse agonists for the treatment of sleep disorders
Read More
Novel atrial K+ channel blockers for prevention of recurrence of atrial fibrillation
Read More
Cytomodulin promotes collagen transcription and wound healing in mice
Read More
VX-950 enters phase I for HCV
Read More
Positive opinion for Apidra in E.U.
Read More
Eloxatin awarded 2004 Prix Galien in France
Read More
Preliminary results from phase II Liprostin trial in peripheral vascular disease
Read More
Metabolic offers progress report
Read More
AD-452 enters phase IIa study for rheumatoid arthritis
Read More
NeuroSearch and Rheoscience collaborate in obesity
Read More
Phase I results for RG-2133 in bipolar disorder and depression
Read More
New phase II program for KRX-0401
Read More
Vanda acquires rights to iloperidone from Novartis
Read More
Aphton begins Swiss regulatory submission for G17DT
Read More
MediciNova acquires anxiety compound from Mitsubishi
Read More
Encouraging phase I results for aminocandin for systemic fungal infections
Read More
Kyorin concludes R&D commission contract with The Scripps Research Institute
Read More
InterMune achieves many objectives during Q1 2004
Read More
Draxis Health highlights first quarter progress
Read More
Penwest highlights first quarter developments
Read More
Preliminary evidence suggests a good safety profile of MLN-2704 in prostate cancer patients
Read More
Good safety and pharmacokinetic profiles of AQ4N in advanced esophageal carcinoma
Read More
NBT-287 and resistance to paclitaxel in human tumor cell lines
Read More
Chemoprotective effects of AES-14 in breast cancer patients with oral mucositis
Read More
New and unique oral delivery system, CAPIC particles, for insulin and other macromolecules
Read More
New dual D2/5-HT2A antagonists and their use claimed by Pfizer
Read More
Sanwa Kagaku presents GLP-1 analogues suitable for oral or intranasal administration
Read More
Novel chemokine receptor modulators identified at Mitsubishi Pharma
Read More
HIV SL9-derived peptides and their use in HIV infection prophylaxis
Read More
New erythromycin-quinolone conjugates prepared and tested by GSK team
Read More
Genzyme researchers claim antigenic gp100 peptides and their use as cancer vaccines
Read More
New buprenorphine prodrugs with potential as topical analgesic agents
Read More